Download DNB 2017 Dec HEMAT HEMAT PAPER II Question Paper

Download Diplomate in National Board (DNB) 2017 Dec HEMAT HEMAT PAPER II Previous Question Papers

FINAL EXAM
DECEMBER 2017
HEMATOLOGY
PAPER-II
Time : 3 hours
Max. Marks 2100
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space
Answer all the parts of a single question together.
Start the question to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/f/owcharts wherever appropriate.
Write short notes on:
1 . a)
b)
C)
2. a)
b
0
vv
Neutrophil function tests
Chediak Higashi syndromes
Granulocyte transfusions
Management of idiopathic hypereosinophilic syndrome
Role of PDGRFa in hypereosinophilia
Acquired eosinophilia
Diagnosis of systemic mastocytosis
Granules of basophils
Causes of basophilia in peripheral blood.
Diagnosis of chronic myelomonocytic leukemia
(CMML).
How does it differ from MDS with excess blasts?
Management of CMML
Infections causing monocytosis.
5. Histomonophagocytic Syndrome:
a)
b)
C)
What are the causes?
Criteria for diag nosis
Langerhan?s cell histiocytosis.
6. Chronic lymphocytic leukemia:
Diagnosis of CLL
How to distinguish it from monoclonal B
lymphocytosis.
The genetic landscape of CLL and the implications in
prognosis.
Current management of CLL
1
.1.
www.FirstRanker.cl?d>??;i0NAL BOWWK?Lcom
HEM/D/17/48/Il
4+3+3
3+4+3
4+3+3
3+2+3+2
3+4+3
2+1+3+4
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
www.FirstRanker.com

FINAL EXAM www.FirstRanker.cl?d>??ii0NAL BOWWK?Lcom
DECEMBER 2017
7. Plasma cells: 4+4+2
a) What are the imaging techniques for the diagnosis of
bone disease in multiple myeloma and their
advantages/disadvantages?
b) Criteria for the diagnosis of multiple myeloma,
smoldering multiple myeloma and MGUS.
c) How to differentiate between multiple myeloma and
lymphoplamacytic lymphoma?
8. a) What is hemovigilance? 5+5
b) How will you implement this in blood bank?
9. a) Risk stratification in MDS 5+5
b) Treatment options in low risk MDS
10. a) Acquired causes of thrombocytosis 2+4+4
b) JAK 2 pathway and its inhibitors in myeloproliferative
neoplasms
0) Management of essential thrombocythemia
*****
?3
.5.
POSSESSION/USE OF CELL PHONES OR ANY S UCH ELECTISONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION HALL.
www.FIrstRanker.com